Skip to content

OMER

Omeros Corporation

NASDAQ · Healthcare · Biotechnology · US

$18.95
−0.84%
Ask drillr
0
Insider buys (3m)
6
Insider sells (3m)
-$1.1M
Net value (3m)
+94.7%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 1, 2026Cancelmo Peter B · officer: VP, General CounselSale25,000$19
Sep 1, 2026Cancelmo Peter B · officer: VP, General CounselM-Exempt25,000$2.94
Aug 28, 2026HANISH ARNOLD C · directorM-Exempt5,000$16
Aug 28, 2026HANISH ARNOLD C · directorSale5,000$19
Aug 28, 2026HANISH ARNOLD C · directorM-Exempt2,500$16
Aug 28, 2026HANISH ARNOLD C · directorM-Exempt7,500$15
Aug 25, 2026Borges David J. · officer: VP, Finance & CAOM-Exempt4,094$2.94
Aug 25, 2026Borges David J. · officer: VP, Finance & CAOM-Exempt5,906$3.93
Aug 25, 2026Borges David J. · officer: VP, Finance & CAOSale906$19
Aug 25, 2026Borges David J. · officer: VP, Finance & CAOM-Exempt906$2.94
Aug 25, 2026Borges David J. · officer: VP, Finance & CAOSale10,000$19
Aug 21, 2026Cable Thomas J. · directorM-Exempt7,500$2.00
Aug 21, 2026Cable Thomas J. · directorSale15,000$18
Aug 18, 2026Schocken Joseph L · directorA-Award30,000$14
Aug 17, 2026Borges David J. · officer: VP, Finance & CAOM-Exempt5,000$3.93
Aug 17, 2026Borges David J. · officer: VP, Finance & CAOSale5,000$17
Jul 24, 2026Cancelmo Peter B · officer: VP, General CounselA-Award105,000$9.84
Jul 24, 2026Borges David J. · officer: VP, Finance & CAOA-Award105,000$9.84
Jul 24, 2026Demopulos Gregory A MD · director, officer: Chairman, CEO & PresidentA-Award1,000,000$9.84
Jun 22, 2026Shah Rajiv · directorA-Award15,000$10
Jun 22, 2026Perkinson Diana T. · directorA-Award15,000$10
Jun 22, 2026Hood Leroy E. MD PhD · directorA-Award15,000$10
Jun 22, 2026HANISH ARNOLD C · directorA-Award15,000$10
Jun 22, 2026Demopulos Peter A MD · directorA-Award15,000$10
Jun 22, 2026Cable Thomas J. · directorA-Award15,000$10
Jun 22, 2026Bumol Thomas F. · directorA-Award15,000$10
May 27, 2026Cable Thomas J. · directorM-Exempt7,500$11
May 27, 2026Cable Thomas J. · directorSale7,500$12
Feb 20, 2026Demopulos Gregory A MD · director, officer: Chairman, CEO & PresidentM-Exempt400,000$10
Feb 20, 2026Demopulos Gregory A MD · director, officer: Chairman, CEO & PresidentF-InKind357,678$12
Institutional positioning

13F filings over the trailing two quarters

New 76Increased 132Reduced 86Sold out 24
FilerActionSharesFiled
BlackRock, Inc.Increased6,044,633Aug 7, 2026
BLACKROCK, INC.Increased5,309,626May 13, 2026
INGALLS & SNYDER LLCIncreased3,659,523Aug 14, 2026
INGALLS & SNYDER LLCIncreased3,559,423May 13, 2026
UBS Group AGIncreased3,148,384Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased3,072,050Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2,983,259May 15, 2026
UBS GROUP AGIncreased2,340,731May 5, 2026
STATE STREET CORPIncreased2,319,906Aug 7, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPIncreased2,215,194Aug 14, 2026
STATE STREET CORPIncreased1,919,575May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased1,914,460Aug 12, 2026
STIFEL FINANCIAL CORPIncreased1,836,925Aug 12, 2026
STIFEL FINANCIAL CORPIncreased1,831,585May 12, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased1,752,323May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 1, 2026